Orchestra BioMed News

Orchestra BioMed Hldgs Analyst Ratings

BenzingaAug 22 19:40

H.C. Wainwright Initiates Orchestra BioMed(OBIO.US) With Buy Rating, Announces Target Price $14

Futu NewsAug 22 18:33

Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $15

Futu NewsAug 13 19:31

Piper Sandler Remains a Buy on Orchestra BioMed Holdings (OBIO)

TipRanksAug 13 18:58

Buy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Developments

TipRanksAug 13 08:07

Orchestra BioMed Sees Expected Operating Cash Runway Into 2H of 2026 Based on Internal Forecast >OBIO

Dow JonesAug 13 04:33

Orchestra BioMed Holdings Price Target Announced at $15.00/Share by B. Riley Securities

Dow JonesJul 26 01:40

Orchestra BioMed Hldgs Analyst Ratings

BenzingaJul 26 01:30

B. Riley Starts Orchestra BioMed Holdings With Buy Rating, $15 Price Target

MT NewswiresJul 25 20:25

Orchestra BioMed Hldgs Analyst Ratings

BenzingaJun 12 19:40

Chardan Capital Reiterates Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target

BenzingaJun 12 19:40

Orchestra BioMed Hldgs Analyst Ratings

BenzingaMar 28 20:50

Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target

BenzingaMar 28 20:50

Piper Sandler Sticks to Its Buy Rating for Orchestra BioMed Holdings (OBIO)

TipRanksMar 28 19:01

Buy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Clinical Data

TipRanksMar 28 07:40

Jefferies Initiates Coverage On Orchestra BioMed Hldgs With Buy Rating, Announces Price Target of $14

BenzingaJan 19 19:28

Orchestra BioMed Hldgs Analyst Ratings

BenzingaJan 19 19:26

Buy Rating for Orchestra BioMed Holdings: An Optimistic Outlook on BACKBEAT and Virtue SAB Studies' Potential Impact and Future Developments

TipRanksNov 21, 2023 00:06

Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Bicycle Therapeutics (BCYC)

TipRanksNov 14, 2023 10:10

Analysts Offer Insights on Healthcare Companies: Reneo Pharmaceuticals (RPHM), Pulmonx (LUNG) and Orchestra BioMed Holdings (OBIO)

TipRanksOct 11, 2023 19:02